造影乳房X光摄影市场规模、份额及成长分析（按应用、最终用户和地区）- 产业预测 2025-2032

预计造影X 光乳房X光摄影市场规模将在 2023 年达到 23 亿美元，2024 年达到 24.4 亿美元，到 2032 年达到 38.9 亿美元，预测期内（2025-2032 年）的复合年增长率为 6.0%。

造影乳房X光摄影靶X光检查（CEM）利用双能量技术，有效结合了数位化乳癌乳房X光摄影X光检查和静脉造影的优势，在诊断场景中比全数位化乳房乳房X光摄影X光检查（FFDM）和超音波在乳癌检测中表现出更高的灵敏度。鑑于全球乳癌发生率不断上升，且老龄化、肥胖和家族病史等风险因素加剧了这一趋势，CEM 的普及度急剧上升，目前已成为主要的影像技术。大多数乳癌病例主要影响女性，凸显了庞大的市场需求。乳房肿块、大小或形状的变化以及分泌物等症状凸显了有效检测解决方案的紧迫性。因此，乳癌率的上升继续推动先进影像技术市场的成长。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析

造影乳房X光摄影市场规模（按应用划分）及复合年增长率（2025 年至 2032 年）

• 市场概览
• 筛检
• 诊断

造影乳房X光摄影市场规模（以最终用户划分）及复合年增长率（2025 年至 2032 年）

• 市场概览
• 医院
• 诊断中心
• 专科诊所
• 其他的

造影乳房X光摄影市场规模（按地区）及复合年增长率（2025 年至 2032 年）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• GE Healthcare（USA）
• Siemens Healthineers（Germany）
• Hologic, Inc.（USA）
• Fujifilm Holdings Corporation（Japan）
• Canon Medical Systems Corporation（Japan）
• Philips Healthcare（Netherlands）
• Carestream Health（USA）
• Konica Minolta, Inc.（Japan）
• Planmed Oy（Finland）
• Sectra AB（Sweden）
• Gamma Medica-Ideas, Inc.（USA）
• SuperSonic Imagine（France）
• iCAD, Inc.（USA）
• ScreenPoint Medical（Netherlands）
• DeepHealth（USA）
• Lunit Inc.（South Korea）
• CureMetrix, Inc.（USA）
• Bracco Imaging SpA（Italy）
• Guerbet（France）

结论和建议

Contrast Enhanced Mammography Market size was valued at USD 2.3 billion in 2023 and is poised to grow from USD 2.44 billion in 2024 to USD 3.89 billion by 2032, growing at a CAGR of 6.0% during the forecast period (2025-2032).

By leveraging a dual-energy technique, Contrast-Enhanced Mammography (CEM) effectively merges the advantages of digital mammography with intravenous contrast, showcasing superior sensitivity in breast cancer detection compared to Full-Field Digital Mammography (FFDM) and ultrasound in diagnostic scenarios. Given the escalating global prevalence of breast cancer-exacerbated by risk factors such as age, obesity, and a family history of the disease-CEM has surged in popularity and is now a leading imaging technique. The majority of breast cancer cases, primarily affecting females, highlight significant market demand. Symptoms like breast lumps, changes in size and shape, and fluid discharge underscore the urgency for effective detection solutions. Consequently, the increasing incidence of breast cancer continues to propel market growth for advanced imaging technologies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Contrast Enhanced Mammography market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Contrast Enhanced Mammography Market Segments Analysis

Global Contrast Enhanced Mammography Market is segmented by Applications, End User and region. Based on Applications, the market is segmented into Screening and Diagnosis. Based on End User, the market is segmented into Hospital, Diagnostic Centres, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Contrast Enhanced Mammography Market

The Contrast Enhanced Mammography market is primarily driven by the increasing prevalence of breast cancer, which stands as the most frequently diagnosed cancer among women globally. Early detection of breast cancer significantly enhances treatment efficacy, allowing for improved patient outcomes. Typically, treatment regimens for breast cancer patients encompass a combination of surgery, radiation therapy, and various medications, including hormone therapy, chemotherapy, and targeted biological therapies. These interventions are crucial in managing the disease, as they not only halt the progression of cancer but also reduce the risk of metastasis, ultimately contributing to higher survival rates and better quality of life for affected individuals.

Restraints in the Contrast Enhanced Mammography Market

The Contrast Enhanced Mammography market faces several significant barriers that could hinder its growth and adoption. Firstly, being a relatively novel technology, the costs associated with the equipment, materials, and necessary training are considerably higher than those for traditional mammography, posing a financial challenge for healthcare providers. Additionally, the limited availability of facilities offering this advanced imaging technique makes it difficult for patients, especially in rural or remote regions, to access these services. Furthermore, obtaining regulatory approval for clinical use is often a lengthy and costly process, potentially delaying market entry. Lastly, despite the encouraging results from clinical studies, the absence of long-term data on the technology's safety and effectiveness may lead some healthcare professionals to exercise caution in embracing this advancement until more substantial evidence is presented.

Market Trends of the Contrast Enhanced Mammography Market

The Contrast Enhanced Mammography (CEM) market is experiencing robust growth, driven by the increasing incidence of breast cancer among women and the demand for advanced diagnostic techniques. As healthcare providers adopt state-of-the-art technologies for early detection, CEM stands out for its superior sensitivity and specificity compared to traditional methods. This trend is fueled by the desire for more accurate and timely results, enabling better treatment decisions. Enhanced imaging technologies not only improve diagnostic performance but also instill greater confidence among patients and healthcare professionals, ultimately propelling market expansion and innovation in breast cancer management solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Contrast Enhanced Mammography Market Size by Applications & CAGR (2025-2032)

• Market Overview
• Screening
• Diagnosis

Global Contrast Enhanced Mammography Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospital
• Diagnostic Centres
• Specialty Clinics
• Others

Global Contrast Enhanced Mammography Market Size & CAGR (2025-2032)

• North America (Applications, End User)
  • US
  • Canada
• Europe (Applications, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Applications, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Applications, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Applications, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carestream Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Konica Minolta, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Planmed Oy (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sectra AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gamma Medica-Ideas, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SuperSonic Imagine (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• iCAD, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ScreenPoint Medical (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DeepHealth (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lunit Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CureMetrix, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bracco Imaging S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guerbet (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations